Mechanisms of essential calcium signaling during gastric epithelial wound healing
胃上皮伤口愈合过程中必需的钙信号传导机制
基本信息
- 批准号:8886564
- 负责人:
- 金额:$ 35.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-05-01 至 2019-04-30
- 项目状态:已结题
- 来源:
- 关键词:ActinsAgonistAnti-Inflammatory AgentsAnti-inflammatoryBiochemicalBiological AssayCDC42 geneCalcium SignalingCell LineCellsCellular StructuresCytoskeletonDependenceDinoprostoneEmployee StrikesEpithelialEpitheliumEventExposure toGasesGastritisHealedHealthcare SystemsHelicobacter InfectionsHelicobacter pyloriImageIn VitroInfectionInterventionLeadLearningLesionLinkMYLK geneMeasuresMediatingMicroscopicModelingMolecularMonomeric GTP-Binding ProteinsMusNHE2OpticsOrganoidsOutcomePathogenesisPathologyPathway interactionsPeptic UlcerPharmaceutical PreparationsPhospholipase CProcessProstaglandin-Endoperoxide SynthaseProstaglandinsProtein Kinase CPylorusRegulationRoleSignal PathwaySignal TransductionSpeedStomachSurfaceTechnologyTestingTherapeuticTight JunctionsTimeTissuesToxic effectUlcerWorkWound Healingbasecell motilitycitrate carrierextracellularhealingimprovedin vivoinhibitor/antagonistinnovationirritationlorismigrationpathogenpublic health relevancerepairedresearch studyresponserhotoolupper GI series
项目摘要
DESCRIPTION (provided by applicant): Peptic ulcer disease and upper GI irritation are a significant burden in the US healthcare system and worldwide, caused in large part by the upper GI toxicity of ingested non-steroidal anti-inflammatory drugs (NSAIDs) and the pathogen H. pylori. The rationale for our work is that improved or alternative therapeutic strategies can be based on understanding the mechanisms of gastric defense rallied against such challenges. Preliminary studies show an essential role for both intracellular and extracellular Ca2+ mobilization in gastric repair of the surface epithelium. We hypothesize that this Ca2+ mobilization is a central regulator of repair that underlies the effects of diverse agonists shown to modulate the repair process, and that this pathway can be disrupted by NSAIDs and H. pylori. The objective of this application is to use the newly identified Ca2+ signals as heralds to identif the underlying upstream and downstream mechanisms mediating gastric repair, and as a tool to investigate if NSAIDs and/or H. pylori compromise repair via these pathways. We have pioneered optical technologies that allow real-time creation of focal damage and continual quantification of repair. Our work focusing on the repair of focal lesions in vivo will be extrapolated to experiments evaluating ulceration to enhance relevance to gastric pathologies observed clinically, and to study of gastric organoids as a potentially powerful new model of gastric epithelial function. Our first aim is to identify the initiating extracellular signals in damaged tissue that stimulate Ca2+ mobilization and gastric repair. We will focus on TFF2 and prostaglandins, shown to be essential to gastric repair, but whose role in Ca2+ signaling is untested. The second aim establishes the hierarchy of Ca2+-dependent intracellular signaling pathways that are essential to allow repair. Experiments are based on preliminary findings that show phospholipase C, and protein kinase C are required for efficient gastric repair in the intact stomach. Our third aim evaluates the downstream targets of Ca2+- dependent signaling that perform the work of gastric repair. We will evaluate the role of the NHE2 Na/H exchanger, shown to be essential for gastric repair as a downstream effector of TFF2. We will also evaluate Ca2+ -dependent regulation of the actin cytoskeleton, tight junctions, and the small GTPases that regulate these cellular structures during repair. All aims focus on the role of the cyclooxygenase (COX)/prostaglandin pathway inhibited by NSAIDs, and the first and third aims additionally examine changes in the studied pathways caused by infection with H. pylori. The outcomes will provide a unique window into understanding early factors in gastric pathogenesis, which have potential to lead to new targets and new strategies for interventions that can minimize gastric damage and speed healing.
描述(由申请人提供):消化性溃疡病和上消化道刺激是美国医疗保健系统和全世界的重大负担,很大程度上是由摄入的非甾体抗炎药(NSAID)和病原体的上消化道毒性引起的我们工作的基本原理是,改进的或替代的治疗策略可以基于了解胃防御机制来应对这些挑战。我们发现,这种 Ca2+ 动员是修复的核心调节因子,是调节修复过程的多种激动剂作用的基础,并且该途径可以被 NSAID 和幽门螺杆菌破坏。本应用的目的是使用新识别的 Ca2+ 信号作为先兆来识别介导胃修复的潜在上游和下游机制,并作为研究是否非甾体抗炎药和/或幽门螺杆菌通过这些途径损害修复。我们开创了光学技术,可以实时产生局灶性损伤并持续量化修复,我们的工作重点是体内局灶性病变的修复,这将被推广到评估实验中。我们的首要目标是识别受损组织中刺激的起始细胞外信号。 Ca2+ 动员和胃修复。我们将重点关注 TFF2 和前列腺素,它们对胃修复至关重要,但其在 Ca2+ 信号传导中的作用尚未经过测试。第二个目标是建立对修复至关重要的 Ca2+ 依赖性细胞内信号传导途径的层次结构。实验基于初步发现,表明磷脂酶 C 和蛋白激酶 C 是完整胃中有效胃修复所必需的。我们的第三个目标是评估执行 Ca2+ 依赖性信号传导的下游靶点。我们将评估 NHE2 Na/H 交换器的作用,该交换器作为 TFF2 的下游效应器对于胃修复至关重要。我们还将评估肌动蛋白细胞骨架、紧密连接和的 Ca2+ 依赖性调节。所有目标都集中在非甾体抗炎药抑制环加氧酶(COX)/前列腺素途径的作用,以及第一个和第三个目标。此外,还检查了幽门螺杆菌感染引起的研究途径的变化,这些结果将为了解胃发病机制的早期因素提供一个独特的窗口,这有可能导致新的目标和新的干预策略,从而最大限度地减少胃损伤和速度。康复。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARSHALL H MONTROSE其他文献
MARSHALL H MONTROSE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARSHALL H MONTROSE', 18)}}的其他基金
Mechanisms of essential calcium signaling during gastric epithelial wound healing
胃上皮伤口愈合过程中必需的钙信号传导机制
- 批准号:
9033115 - 财政年份:2015
- 资助金额:
$ 35.57万 - 项目类别:
Sealing and Healing of Epithelial Gaps during Cell Shedding and Disease
细胞脱落和疾病期间上皮间隙的封闭和愈合
- 批准号:
7898170 - 财政年份:2009
- 资助金额:
$ 35.57万 - 项目类别:
Repairing pre-epithelial defenses after gastric damage
修复胃损伤后的上皮前防御
- 批准号:
7845905 - 财政年份:2009
- 资助金额:
$ 35.57万 - 项目类别:
Gastrointestinal Response to Injury: Canada 2007
对损伤的胃肠道反应:加拿大 2007 年
- 批准号:
7406574 - 财政年份:2007
- 资助金额:
$ 35.57万 - 项目类别:
Sealing and Healing of Epithelial Gaps during Cell Shedding and Disease
细胞脱落和疾病期间上皮间隙的封闭和愈合
- 批准号:
7496483 - 财政年份:2007
- 资助金额:
$ 35.57万 - 项目类别:
Sealing and Healing of Epithelial Gaps during Cell Shedding and Disease
细胞脱落和疾病期间上皮间隙的封闭和愈合
- 批准号:
7313914 - 财政年份:2007
- 资助金额:
$ 35.57万 - 项目类别:
Arcturus Veritas Microdissection Microscope
Arcturus Veritas 显微解剖显微镜
- 批准号:
7040279 - 财政年份:2006
- 资助金额:
$ 35.57万 - 项目类别:
ARCTURUS VERITAS MICRODISSECTION MICROSCOPE: PULMONARY DISEASES
ARCTURUS VERITAS 显微切割显微镜:肺部疾病
- 批准号:
7335221 - 财政年份:2006
- 资助金额:
$ 35.57万 - 项目类别:
ARCTURUS VERITAS MICRODISSECTION MICROSCOPE: PHYSIOLOGY
ARCTURUS VERITAS 显微切割显微镜:生理学
- 批准号:
7335220 - 财政年份:2006
- 资助金额:
$ 35.57万 - 项目类别:
ARCTURUS VERITAS MICRODISSECTION MICROSCOPE: RENAL
ARCTURUS VERITAS 显微切割显微镜:肾脏
- 批准号:
7335222 - 财政年份:2006
- 资助金额:
$ 35.57万 - 项目类别:
相似国自然基金
FOXD1-SFRP2及其特异性激动剂在骨关节炎中的功能及作用机制探究
- 批准号:82372438
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
脂质纳米粒体内介导嵌合抗原受体-M1型巨噬细胞协同TLR激动剂治疗实体瘤的研究
- 批准号:82304418
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
新型IL2Rβγ激动剂逐级控释联合放疗对抗三阴性乳腺癌的作用及机制研究
- 批准号:82303819
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
TRPV4/SKCa信号轴在AMPK激动剂抑制微小动脉舒张作用中的机制研究
- 批准号:82304584
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
靶向STING激动剂和TREM2抑制剂增强PD-1抑制剂对胰腺癌的抗肿瘤作用研究
- 批准号:82303740
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Evaluation of anti-fibrotic and anti-inflammatory semi-synthetic oxysterol, Oxy210, as a therapeutic drug candidate for non-alcoholic steatohepatitis
抗纤维化和抗炎半合成氧甾醇 Oxy210 作为非酒精性脂肪性肝炎候选治疗药物的评价
- 批准号:
10697132 - 财政年份:2023
- 资助金额:
$ 35.57万 - 项目类别:
Mitochondrial translocator protein: a target for bronchodilation
线粒体易位蛋白:支气管扩张的靶点
- 批准号:
10432105 - 财政年份:2021
- 资助金额:
$ 35.57万 - 项目类别:
Adipose tissue immunometabolism in ovarian cancer progression and chemoresistance
卵巢癌进展和化疗耐药中的脂肪组织免疫代谢
- 批准号:
10608217 - 财政年份:2021
- 资助金额:
$ 35.57万 - 项目类别:
Adipose tissue immunometabolism in ovarian cancer progression and chemoresistance
卵巢癌进展和化疗耐药中的脂肪组织免疫代谢
- 批准号:
10640226 - 财政年份:2021
- 资助金额:
$ 35.57万 - 项目类别:
Mitochondrial translocator protein: a target for bronchodilation
线粒体易位蛋白:支气管扩张的靶点
- 批准号:
10298047 - 财政年份:2021
- 资助金额:
$ 35.57万 - 项目类别: